Expert Opinion on Therapeutic Targets

Advantages of voltage-gated ion channels as drug targets
pp. 265-271(7)
Author: McGivern, Joseph G

Mechanisms of action of statins in stroke
pp. 273-278(6)
Authors: Tuñón, José; Martín-Ventura, José Luis; Blanco-Colio, Luis Miguel; Egido, Jesús

Antimalarial drug discovery: targeting protein kinases
pp. 279-290(12)
Authors: Doerig, Christian; Meijer, Laurent

Blocking sodium channels to treat neuropathic pain
pp. 291-306(16)
Authors: Priest, Birgit T; Kaczorowski, Gregory J

Inflammatory mediators modulating the transient receptor potential vanilloid 1 receptor: therapeutic targets to treat inflammatory and neuropathic pain
pp. 307-320(14)
Authors: Ma, Weiya; Quirion, Rémi

The hERG potassium channel as a therapeutic target
pp. 321-336(16)
Author: Witchel, Harry J

HER family inhibitors in pancreatic cancer: current status and future directions
pp. 337-347(11)
Authors: Berz, David; Miner, Thomas; McCormack, Elise; Safran, Howard

S-Alkylthiolation of O⁶-methylguanine-DNA-methyltransferase (MGMT) to sensitize cancer cells to anticancer therapy
pp. 349-361(13)
Authors: Juillerat, Alexandre; Juillerat-Jeanneret, Lucienne

Myeloid cell leukemia-1 as a therapeutic target
pp. 363-373(11)
Authors: Mandelin, Arthur M; Pope, Richard M

Targeting the Wnt signaling pathway to treat Barrett's esophagus
pp. 375-389(15)
Authors: Clément, Geneviève; Jablons, David M; Benhattar, Jean

Transient receptor potential channels as drug targets
pp. 391-401(11)
Authors: Okuhara, Dayne Y; Hsia, Albert Y; Xie, Michael

Cannabinoid receptors as new targets of antifibrosing strategies during chronic liver diseases
pp. 403-409(7)
Authors: Mallat, Ariane; Teixeira-Clerc, Fatima; Deveaux, Vanessa; Lotersztajn, Sophie

Pathway analysis software as a tool for drug target selection, prioritization and validation of drug mechanism
pp. 411-421(11)
Authors: Sivachenko, Andrey Y; Yuryev, Anton